Solving Epidemics of Lyme and Other Vector-Borne Infections through the Immune System

Abstract

Vector-borne infections such as Lyme disease and co-infections, rickettsiosis, dengue, West Nile fever, and malaria that are known for their high morbidity, and even mortality, have been globally on the rise due to several key factors. Among these are the increased population of and exposure to ticks and mosquitoes that are caused by climate change and deforestation, as well as a generally more health-compromised population as evidenced by skyrocketing prevalence of chronic diseases. The implicated factors in chronic sickness are continual rise in environmental pollution, unhealthy diet and substance abuse, overuse of antibiotics leading to microbial evolvement into more aggressive forms, disturbed biome, secondary fungal infections and antimicrobial resistance (AMR). Some of the most common vector-borne infections lack effective treatments, including chronic post-treatment Lyme disease with diagnostic tests not always being reliable. Additionally, Lyme's Borrelia Burgdorferi, that is the most common vector-borne disease in North America and Europe, presents a particular challenge to its treatments by existing in many different genotypes with some being particularly aggressive. This article presents a different approach to vector-borne, and infections in general, based on several principal factors. These concern the increased focus on the host innate immunity to defeat infectious agents using a novel diagnosis to ascertain reasons for suboptimal immunity, treatment to address this and elicit proper immune stimulation by vaccine-like action. Both diagnosis and treatment concern energy medicine, which is formally recognized by the NIH, and based on the physics of the living, water, and all matter in nature.